Login
REVVITY, INC. logo

REVVITY, INC.

revvity.com

What Do They Do?

Sells research instruments, reagents and software, plus diagnostic instruments and consumables, to drug developers, research institutions and diagnostic laboratories.

How Do They Make Money?

Most revenue comes from products: customers pay for instruments, reagents and certain software when delivered. Service revenue generally comes in over the service or contract period.

revenue
SegmentShareRevenue
Product
Sold outright

84%
FY2022: 80%
Service
Recurring

16%
FY2022: 20%

Who Are Their Customers?

Drug developers and research institutions, diagnostic laboratories, and healthcare organizations buy products and services. Revvity sells mainly through its own sales force and uses distributors where it has no direct sales presence.

Do Revenues Turn Into Profits?

Yes. It kept 8 cents of every revenue dollar as net income in FY2025 and turned 18 cents into free cash flow.

Operating income, FY2025
12% of revenue
▲ +3% vs FY2024 ($346.7M, 13%)
Net income, FY2025
8% of revenue
▼ −11% vs FY2024 ($270.4M, 10%)
Free cash flow, FY2025
18% of revenue
▼ −6% vs FY2024 ($541.7M, 20%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Oct 4, 2026
Revenue
▲ +4%
vs $698.9M in Q3 FY2025
Net income
▲ +34%
vs $46.7M in Q3 FY2025
Product share of revenue vs 82.0% in Q3 FY2025
  • Nov 3, 2026 Agreed to sell China immunodiagnostics business and raised guidance China IDX represented approximately 6% of FY2025 revenue; the sale is expected to close by the end of 2027.

Shrinking. Revenue fell 25% in 4 years, from $3.8B in FY2022 to $2.9B in FY2025, about 7% a year.

Applied markets exit The older report included environmental, food and industrial analytical products and services within Discovery & Analytical Solutions and described a planned sale of certain businesses. The latest report describes Life Sciences and Diagnostics segments instead.

Revenue over time
Product Service
$5B$2.5B$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support